Patent · US Active

Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereof

US10561647B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN

Inventors

Xunqiang Wang · 安丰镇, CN
Ling Yang · Lianyungang, CN
Zhongnan Xu · Lianyungang, CN
Xiangjian Wang · 安丰镇, CN
Wenjun Geng · Lianyungang, CN

Key dates

Filing date	Jan 6, 2017
Grant date	Feb 18, 2020
Priority date	—
Expiry date	Jan 6, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided in the present invention are a use of quinoline derivatives for treating oesophageal cancer and a treatment method, a pharmaceutical composition and a kit thereof. The 1-[[[4-(4-fluoro-2-methyl-1H-indole-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropylamine provided by the present invention can effectively treat oesophageal cancer, and reduce the sum of the diameters of patient's target lesions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.